A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/48 (2006.01) A61K 38/17 (2006.01) A61K 38/22 (2006.01) A61K 51/04 (2006.01) A61P 25/06 (2006.01) C07K 14/575 (2006.01) C07K 17/00 (2006.01)
Patent
CA 2624175
Disclosed is a composition of matter that involves a CGRP peptide antagonist. A pharmaceutical composition is disclosed that comprises the composition of matter and a pharmaceutically acceptable carrier, which can be configured for administration to a patient. Also disclosed is a method of producing the composition of matter. Methods of treating, preventing or mitigating migraine, are also disclosed.
La présente invention concerne une composition de matière impliquant un antagoniste de peptide CGRP. Elle concerne également une composition pharmaceutique comprenant ladite composition de matière et un support pharmaceutiquement acceptable, qui peut être adaptée à une administration à un patient. En outre, cette invention concerne un procédé pour produire ladite composition de matière, ainsi que des procédés pour traiter, prévenir ou atténuer une migraine.
D'amico Derin C.
Gegg Colin V. Jr.
Holder Jerry Ryan
Johnson Eileen J.
Miranda Leslie P.
Amgen Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Cgrp peptide antagonists and conjugates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cgrp peptide antagonists and conjugates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cgrp peptide antagonists and conjugates will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1929660